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The  increased  pericardial  fat which  often  accompanies  overall  obesity  is  thought  to  alter  cardiac  struc-
ture/function  and  increase  the  risk for atrial  ﬁbrillation.  We  hypothesized  that chronic  exposure  to
bisphenol  A  (BPA)  would  induce  pericardial  fat,  cardiac  hypertrophy  or arrhythmia.  C57bl/6n  dams  were
exposed  to  BPA  (25 ng/ml  drinking  water)  beginning  on  gestation  day  11 and  progeny  continued  on  2.5 ng
BPA/ml  drinking  water.  The  progeny  of  control  dams  (VEH)  and  dams  treated  with  diethylstilbestrol  (DES,
1 g/kg/day,  gestation  days  11–14)  had  tap  water.  After  weaning  progeny  were  fed  either  a control  (CD)
or  high  fat  diet  (HFD)  for  3 months.  Pericardial  fat was present  in CD-BPA  and  CD-DES  and  not  CD-VEH
mice,  and  was  increased  in all HFD  mice.  Catecholamine  challenge  revealed  no  differences  in  males,  but
BPA-exposed  females  had longer  P-wave  and  QRS complex  duration.  Only  CD-BPA  and  CD-DES  femaleschocardiograph
alcium homeostasis
developed  cardiac  hypertrophy  which  was  independent  of increased  blood  pressure.  Calcium  homeosta-
sis protein  expression  changes  in  HFD-BPA  and  HFD-DES  mice  predict  reduced  SERCA2  activity  in  males
and  increased  SERCA2  activity  in  females.  Thus,  chronic  BPA  exposure  induced  pericardial  fat  in  the
absence  of HFD,  and female-speciﬁc  changes  in  cardiac  hypertrophy  development  and cardiac  electrical
conduction  after  a catecholamine  challenge.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Obesity is a risk factor for cardiovascular disease [27]. One rea-
on may  be because the increase in pericardial fat which often
ccompanies overall obesity alters cardiac structure/function and
n some studies increased the risk for atrial ﬁbrillation [2,17–19].
eft ventricle mass (LVM) is greater in obese versus lean humans
ven when ancillary co-morbidities are absent [28]. Similarly in an
nimal model, high fat diet (HFD) fed male C57bl/6j mice became
bese and developed increased LVM [10].
Epidemiological analyses correlate increased exposure to the
strogenic endocrine disruptor bisphenol A (BPA) suggesting that
PA may  promote obesity and cardiovascular disease [29,36,37,56].
upporting the epidemiological results, early life exposure to BPA
r the estrogenic compound diethylstilbestrol (DES) in mice and
∗ Corresponding author at: Lady Davis Institute for Medical Research, Jewish Gen-
ral Hospital, 3755 chemin Cote Ste Catherine, Montreal, Quebec H3T 1E2, Canada.
ax: +1 514 340 7502.
E-mail address: lorraine.chalifour@mcgill.ca (L.E. Chalifour).
ttp://dx.doi.org/10.1016/j.toxrep.2015.09.008
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
rats was  correlated with increased body size and body weight in
the adult progeny [26,38,51,60]. In contrast, chronic exposure to
BPA did not lead to increased body size [30,42].
Acute BPA treatment of excised heart preparations has induced
cardiac electrical conduction abnormalities and cardiac arrhyth-
mia. In ex vivo rat heart preparations, BPA prolonged arrhythmia
events after ischemic/reperfusion [63], decreased atrial contrac-
tility [41] and prolonged atria to ventricle conduction [46].
Moreover, BPA promoted premature ventricular beats and ventric-
ular tachycardia when isolated cardiomyocytes were stimulated by
catecholamines, and induced these effects by altering sarcoplasmic
reticulum calcium handling [62].
Previously, we  found gestational exposure to the estrogenic
chemical diethylstilbestrol (DES) altered heart structure/function
in male and female mice [24,25]. The inclusion of a DES  arm in stud-
ies of low dose estrogenizing endocrine disruptor activity has been
suggested [50]. In essence, the physiological response to DES expo-
sure is considered to afford a proof in principle of the potential for
estrogenic endocrine disruptor impact. Accordingly, we  used DES as
a positive control and to test whether gestational exposure would
alter response to a HFD. Based on the above evidence, we hypoth-
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Fig. 1. (A) A schematic indicating the timing of treatments, initiation of diet changes and analyses. (B and C) Mice, n = 6–9 mice/treatment/sex/diet, were euthanized and the
BW  and pericardial fat weighed. Body surface area was calculated from the BW at euthanasia. Data are expressed as mean ± SEM. Signiﬁcance, indicated by p < 0.05 when
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ave  duration (P-dur), QRS and QT corrected for HR (QTc) are plotted with time. T
hen  compared with * VEH.
sized that mice chronically exposed to oral BPA would develop
ncreased pericardial fat, cardiac hypertrophy and overt arrhyth-
ia. Here, we report on the cardiac impact of chronic oral BPA
xposure in male and female mice fed a control diet (CD) or high
at diet (HFD) measuring pericardial fat deposition, cardiac struc-
ure/function, blood pressure and ECG, and expression of calcium
andling proteins.
. Methods
.1. Animal manipulation and test chemicals
The animal care protocol was reviewed by the Lady Davis Insti-
ute Animal Care Committee and experiments were performed
ccording to Canadian Council on Animal Care guidelines. C57bl/6n
ice were purchased (Charles River, St. Constant, Que.). All dams
ere fed a natural ingredient all-purpose soy-based diet (Har-an Teklad Global 2018 diet, 3.1 Kcal/gm, 6.2% fat, 18% calories
rom fat) during gestation and lactation. All mice were housed in
tandard cages with 1/4” corn cob bedding and a 12 h dark/light
chedule. C57bl/n males and females, purchased from Charles Rivered mice and ECG data collected after IP isoproterenol injection. Heart rate (HR), P
ow indicates peak HR. Data are the mean ± SEM. Signiﬁcance, indicated by p < 0.05
Canada (St. Constant, Quebec), were housed together. The females
were examined daily for the presence of a vaginal plug and once
detected, were separated from the males. A schematic showing
the timing of treatments, diet changes and analyses is shown in
Fig. 1A.
BPA (>99% pure, CAS 80-05-7, Sigma–Aldrich, Oakville, Ont.) was
dissolved in ethanol, and added to glass-bottled drinking water.
BPA exposed dams, n = 11, were treated with BPA-containing drink-
ing water, 25 ng/ml, from gestation day 11.5 until pup weaning
on post-natal day 21. Vehicle (VEH) treated dams, n = 10 and their
progeny had an equal volume of ethanol, ﬁnal concentration 0.1%,
added to the drinking water. At weaning, BPA in the drinking water
was reduced to 2.5 ng/ml and progeny continued on this treat-
ment until euthanasia. At 4 months of age, spot urine was collected
between 8 and 9 AM from BPA-exposed mice, n = 6. Animals were
placed on a glass petri dish, urine collected using a glass pipet
and placed in polypropylene tubes. Urine total BPA was  quanti-
ﬁed by the Institut National de Santé Publique du Québec using gas
chromatography-tandem mass spectrophotometry [48]. The detec-
tion limit in this analytic method is 0.2 g/L urine. Field blanks
reported undetectable BPA.
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Fig. 2. (A) Mice, n = 6–9/treatment/sex/diet, were anesthetized and echocardiography performed. Left ventricle mass (LVM), LVM indexed to body surface area (LVM/BSA)
and  relative wall thickness (RWT) were calculated. Mice were euthanized after echocardiography and lungs weighed. Data are the mean ± SEM. Signiﬁcance, indicated by
p  < 0.05 when compared with * VEH and † CD. (B) M-mode images from representative acquisitions of female VEH, BPA and DES mice are shown. The white lines indicate the
interventricular wall in diastole (IVSd), left ventricle inner diameter in diastole (LVIDd) and left ventricle posterior wall in diastole (LVPWd), respectively. (C and D) Heart
sections, n = 3/treatment/sex/diet, were stained with H&E (panel C) or sirius red (panel D). Photographs of representative sections are presented. The black bars in panels C
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Diethylstilbestrol (DES, 99% pure, CAS 56-53-1, Sigma–Aldrich,
akville, Ont.) was dissolved in peanut oil and administered orally
y a micropipettor to deliver 1.0 g DES/kg body weight (BW)/day
n gestation days 11.5–14.5 to n = 10 dams. This method was shown
reviously to increase adult BW [26].
At weaning on post-natal day 21, 2 mice of each sex/litter were
andomly selected to one of two diets. The number of mice used for
ach analyses are presented in Supplementary Table 1. Mice were
aintained on the diets until euthanasia at 4 months of age. These
asein-based and puriﬁed component diets were either low (con-
rol diet, CD) (Teklad TD6416, 3.7 Kcal/g, 4.2% fat, 10% of calories
rom fat) or high in fat (HFD) (Teklad TD6414, 5.1 Kcal/g, 34% fat, 60%
alories from fat). Body weight did not differ within the treatment
roups when randomized. Diet components are presented in Sup-
lementary data, Supplemental Tables 2 and 3. Two  independent
ohorts were analyzed. Water and food were ad libitum.
.2. Cardiac function analyses
.2.1. Surface electrocardiography (ECG)
At 15 weeks of age, mice, n = 9–11/treatment/sex/diet, were
nesthetized with isoﬂurane. Surface ECG data was collected for
 min  using IOX2 software, (EMKA Technologies, Inc., Falls Church,
A). In a second set of CD mice, n = 8–10 mice/treatment/sex, base-e highlighted area. Female (VEH-F, BPA-F and DES-F) and male (VEH-M, BPA-M and
sorganized structure and vacuolation. In panel D, arrows point to sirius red stained
line ECG data was  obtained for 2 min, the mice injected with 0.5 g
isoproterenol/kg BW and data collected for 10 min. Recordings
were collected once from each animal. Waves were analyzed using
ecgAuto v2.8.1.11 software (EMKA Technologies, Inc., Falls Church,
VA) and collated in 10 s blocks. Changes were considered signiﬁcant
if they persisted for greater than 30 s.
2.2.2. Tail cuff blood pressure
At 15 weeks of age, tail cuff blood pressure (BP) was  measured in
conscious mice, n = 6–10/treatment/sex/diet, using a Hatteras MC-
4000 BP analysis system (Cary, NC). Mice were accustomed to the
apparatus for 3 days. Measurements were recorded on days 4 and
5 when the heart rate was between 500 and 700 beats per minute.
2.2.3. Echocardiography
At ∼16 weeks of age, echocardiography of anesthetized mice,
n = 6–9/treatment/sex/diet, was performed using a VEVO 770 sys-
tem (VisualSonics, Toronto, Ont) and analyzed with VisualSonics
proprietary software as described previously [24,25,43]. Brieﬂy,
M-mode acquisitions were used to measure left ventricular (LV)
dimensions and LV posterior wall (LVPW) and interventricu-
lar septal wall (IVS) thicknesses. Fractional shortening (FS) was
calculated as [(LVIDd-LVIDs)/LVIDd] × 100 where LVIDd is the
LV internal diameter at diastole and LVIDs is the LV internal
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iameter in systole. Left ventricle mass (LVM) was calculated
s 1.055[(LVPW + IVS + LVIDd)3 − (LVIDd3)]. Relative wall thickness
RWT) was calculated as (LVPW + IVS)/LVIDd. LV volume in diastole
as calculated using the formula [7.0/(2.4 × LVIDd)] × LVIDd3. LV
olume in systole was calculated using the same formula except
hat the LVIDs was used. Ejection fraction is the LV volume in sys-
ole divided by the LV volume in diastole. Stroke volume (SV) is the
ifference between the LV volume in diastole and the LV volume
n systole. Cardiac output (CO) is stroke volume multiplied by the
eart rate. Pulsed-wave Doppler images of the ascending aorta (Ao)
nd the pulmonary artery (PA) were used to measure the velocity
ime integral (VTI).
.3. Physiological parameters
Body, heart, lung and pericardial fat weights were measured at
uthanasia. Pericardial fat included the fat immediately surround-
ng the heart and thoracic cavity. Fat surrounding the aortic arch
as not included. Hearts were placed in buffered formalin or imme-
iately frozen and stored at −80 ◦C. Body surface area (BSA) was
alculated using the formula BSA = [K × (3
√
W2)] where K is 10.5
he species speciﬁc constant for mice, and W is the BW in grams
16].
.4. Protein expression analysis
Ventricles, n = 5–7/treatment/sex/diet, were homogenized in
IPA buffer (1% NP-40, 50 mM Tris (pH 7.4), 0.5% deoxycholate,
59 mM  NaCl, 0.1% SDS, 10 mM sodium metabisulﬁte, 1 mM  sodium
anadate, proteinase inhibitor cocktail, PhosSTOP (Roche, Indi-
napolis, IN), and 1 mM PMSF). Protein was measured using the
radford Protein Determination Assay (BioRad, Hercules, CA) as per
he manufacturer’s instructions.Protein expression was measured using standard immunoblot-
ing methods. Primary antibodies to the cardiac calcium
omeostasis proteins sodium calcium exchanger-1 (NCX1, Abcam
nc, Cambridge, MA  ab6495); sarcoplasmic calcium ATPase 2aots performed. Expression in VEH mice was  set to 1.0. Representative immunoblots
h protein on each mouse sample. Data are the mean ± SEM. Signiﬁcance, indicated
(SERCA2a, Santa Cruz Biotechnology, Santa Cruz, CA, sc-8095);
cardiac calsequestrin 2 (CASQ2, Abcam Inc, Cambridge, MA,
ab626662); phospholamban (PLB, Thermo Scientiﬁc, Nepean, ONT,
MA3-922); and phospho-serine 16-speciﬁc PLB (pS16-PLB, Milli-
pore, Temecula, CA, 07-052 1) were obtained. Secondary antibodies
complexed to horseradish peroxidase and chemiluminescent
detection kits were obtained from Pierce Chemical Co., (Rockford,
IL). Several exposures from each membrane were collected onto
X-ray ﬁlm. After immunoblotting, membranes were washed, per-
manently stained with Coomassie Brilliant Blue, destained and
scanned. The bands on the X-ray ﬁlm and stained membrane were
scanned and quantitated using Image J software.
2.5. Histology
Hearts, n = 5/treatment/sex/diet, were ﬁxed with buffered for-
malin and parafﬁn embedded. Sections, 6 microns, were stained for
Hematoxylin and Eosin (H&E) by the Lady Davis Institute Pathol-
ogy Core or with Picric Acid Sirius Red (Polysciences, Warrington,
PA) according to the manufacturer’s instruction. Stained sections
were photographed using a Leica DM2000 microscope and Inﬁnity
Capture v4.6 software (Lumenera Corp. Ottawa, Ont).
2.6. Statistical analyses
The Kolmogorov–Smirnov test was  used to establish equal vari-
ance about the group mean prior to ANOVA analyses. Signiﬁcance
was evaluated using two-way ANOVA, the statistical program
SigmaStat 3.1 and the Student–Newman–Keuls post-hoc test. Sig-
niﬁcance for physiology parameters was  also assessed by ANCOVA
using litter size as a covariate and the SPSS version 20 Statistical
package. A p-value of <0.05 was considered signiﬁcant.
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Table 1
Electrocardiograph parameters.
Male Female
CD HFD CD HFD
VEH BPA DES VEH BPA DES VEH BPA DES VEH BPA DES
PR 37.5 ± .08 38.8 ± 0.7 38.1 ± 0.7 39.8 ± 1.1 37.4 ± 0.9 39.5 ± 0.9 42.3 ± 1.2 41.2 ± 1.3 40.0 ± 1.0 43.1 ± 1.5 40.0 ± 1.4 41.1 ± 1.4
P-dur  16.8 ± 0.8 17.2 ± 0.6 18.0 ± 0.6 16.4 ± 1.0 17.1 ± 0.9 17.7 ± 0.9 17.9 ± 0.7 18.4 ± 0.7 17.6 ± 0.6 18.8 ± 0.8 18.4 ± 0.7 17.6 ± 0.8
 ± 0.4 
 ± 1.4 
 ± 11 
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cQRS  13.0 ± 0.4 13.4 ± 0.3 12.8 ± 0.3 13.8 ± 0.5 12.6 ± 0.4 12.6
QTc  37.9 ± 1.3 38.1 ± 1.3 40.5 ± 1.2 37.6 ± 1.6 41.7 ± 1.4 39.6
HR  579 ± 14 579 ± 8 539 ± 16 520 ± 25 546 ± 14 526
. Results
.1. BPA exposure, BW at euthanasia and pericardial fat
eposition
Most human exposure to BPA is continuous as BPA leaches into
onsumed food and beverages [21]. Accordingly, we continuously
xposed mice to oral BPA via their drinking water. To simulate
he higher exposure of children versus adults [6], we treated the
ice with a higher dose during gestation and lactation and reduced
he dose of BPA at weaning. Using BW measurements to esti-
ate water intake [3], BPA exposure of the adult progeny averaged
0.55 ± 0.08 g/kg/day. To verify this exposure, we  collected early
orning spot urine samples from 6 mice of 4 months of age and
uantiﬁed urine BPA. The amount of BPA averaged 17.7 ± 3.7 ng/ml
rine. Assuming a 2 ml  urine output/day, the calculated [64] BPA
xposure was 1.1 ± 0.3 g/kg/day which corresponds to a human
quivalent dose of 0.09 g/kg/day [49]. This level is considered to
e “low dose” and to approximate human exposure levels [54,59].
To measure whether chronic BPA exposure increased BW,  we
easured BW at euthanasia, Fig. 1B. In males, treatments had no
mpact on BW of mice fed the CD, yet BPA and DES treatments
educed BW when fed the HFD. In females, the BW of CD-BPA
nd CD-DES females did not differ from that of CD-VEH females.
n contrast, whereas the BW of HFD-BPA and HFD-VEH females
ere similar, the BW of HFD-DES females was signiﬁcantly reduced.
hus, chronic BPA exposure had no impact on BW in mice fed the
D or HFD.
Pericardial fat was quantiﬁed at euthanasia to determine
hether chronic BPA exposure would increase its deposition,
ig. 1C. Pericardial fat was present in male and female CD-BPA and
D-DES mice, and absent in CD-VEH mice. In mice fed the HFD, peri-
ardial fat was increased similarly, regardless of treatment. When
D and HFD mice were compared, HFD-VEH and HFD-DES mice
ad increased indexed pericardial fat when compared with their
D cohorts. Thus, BPA- and DES-exposure induced pericardial fat
eposition in mice that were not obese or fed the HFD, but did not
nhance pericardial fat accumulation in HFD mice.
.2. Electrocardiography
To establish whether chronic BPA exposure and increased peri-
ardial fat deposition would alter cardiac electrical conduction,
e performed surface ECG analysis. All ECG parameters measured
ere similar, regardless of treatment, Table 1. No ECG parameters
iffered when CD versus HFD mice were compared. Thus, BPA and
ES exposure and the increased pericardial fat on the CD diet had
o impact on cardiac electrical conduction in unstressed male or
emale hearts in vivo.
To determine whether catecholamine stress would reveal
hanges in electrical conduction, we injected CD mice with the
-adrenergic agonist, isoproterenol, and gathered ECG data for
he next 10 min, Fig. 1D. All mice increased HR similarly after
atecholamine injection. In males, no differences were detected12.7 ± 0.4 12.9 ± 0.4 13.5 ± 0.3 12.8 ± 0.5 13.2 ± 0.4 12.3 ± 0.5
38.6 ± 1.1 39.1 ± 1.1 39.4 ± 0.9 38.8 ± 1.3 38.6 ± 1.2 38.0 ± 1.3
546 ± 13 584 ± 17 545 ± 16 550 ± 21 577 ± 21 533 ± 12
with time post-injection suggesting no change in the response to
catecholamine stimulation. When the HR was maximal the QRS
complex was  prolonged in CD-BPA females and the QTc interval
was reduced in CD-DES females compared with CD-VEH females.
P-wave duration was longer in CD-BPA versus CD-VEH females
as the HR returned to baseline levels. Thus, catecholamine chal-
lenge revealed female-speciﬁc alterations in P-wave control and
QRS complex regulation with chronic BPA exposure.
3.3. Cardiac structure and blood pressure analyses
We  performed echocardiography to measure cardiac structure,
Fig. 2. LVM, LVM indexed to BSA and RWT  were unaffected by
treatment in males fed the CD, Fig. 2A. However, the increased
LVM, indexed LVM and RWT  in CD-BPA and CD-DES versus CD-VEH
females suggests concentric hypertrophy development in treated
females, Fig. 2A and B. The lack of any increase in lung weight in any
group suggests no overt heart failure as a consequence of treatment
or diet.
To determine whether chronic BPA exposure increased BP and
whether this increase might contribute to the increased LVM in
female mice, we measured tail cuff BP, Table 2. We did not detect a
difference in SBP among the male or female groups fed the CD sug-
gesting that the increase in LVM in CD-BPA and CD-DES females is
unlikely to be secondary to hypertension. H&E and Sirius Red stain-
ing of LV sections were essentially similar in CD mice regardless of
treatment or sex suggesting no gross histological change, Fig. 2C
and D.
Within the HFD groups, LVM, indexed LVM and RWT, Fig. 2A, as
well as SBP, Table 2, were similar in HFD-VEH and HFD-BPA males
and females. However, HFD-DES males had increased LVM when
compared with HFD-VEH males. Although it did not reach a level
considered to be hypertensive, >140 mmHg, the slight increase in
SBP to 113 ± 5 mmHg in HFD-DES males may  have contributed to
their LVM increase. H&E staining of LV sections from HFD-BPA and
HFD-DES males and females revealed cardiomyocytes with some
vacuolation and disorganized structure; however, the similar Sirius
Red staining in heart sections from the HFD-fed groups indicates no
increase in ﬁbrosis, Fig. 2C and D.
When CD and HFD mice were compared, HFD-VEH males and
females had increased LVM and no change in indexed LVM or RWT.
This suggests that an increase in LVM is a normal accommoda-
tion to facilitate heart function in a heavier animal. HFD-BPA males
remodeled similarly to HFD-VEH males. However, HFD-DES males
showed an increase in LVM as well as indexed LVM when com-
pared with their CD-DES cohort. In females, HFD-BPA and HFD-DES
females had no increase in LVM, indexed LVM or RWT  when com-
pared with their CD-cohorts. Thus, in males, BPA and DES  exposure
did not induce a difference in cardiac structure in CD and chronic
BPA exposure did not inﬂuence the response to a HFD. In females,
chronic BPA exposure induced concentric hypertrophy in mice fed
the CD which was not increased further with the HFD. We  con-
clude that chronic BPA exposure preferentially inﬂuenced cardiac
structure remodeling in females.
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3.4. Echocardiograph-derived cardiac systolic function analyses
To determine whether BPA would induce cardiac systolic func-
tion, we measured LV and RV function by echocardiography,
Table 2. In CD males, LV and RV function parameters were similar,
regardless of treatment. In females, CD-VEH and CD-BPA females
were also similar. In contrast, CD-DES females had increased PAVTI
compared with CD-VEH females suggesting an increase in RV stroke
volume. Thus, when fed the CD, chronic exposure to BPA had no
impact on LV and RV function, and DES exposure inﬂuenced RV
function only in females.
HFD-VEH and HFD-BPA males and females showed no differ-
ences in LV systolic function suggesting no impact of BPA exposure.
In contrast, the reduced FS and EF as well as greater LVIDs in HFD-
DES versus HFD-VEH males indicates functional deﬁcits with DES
exposure. In HFD females, no differences in LV parameters were
detected with treatment. However, the increase in the RV indica-
tor PAVTI in HFD-BPA and HFD-DES treated mice compared with
HFD-VEH females, suggests an increase in RV SV was  necessary to
accommodate the HFD in these groups. Overall, BPA exposure did
not worsen the impact of a HFD on LV systolic function, DES expo-
sure reduced LV systolic function, and both treatments remodeled
RV systolic function only in females.
When CD versus HFD males were compared, HFD-VEH males
had increased SV and CO compared with CD-VEH males suggesting
that these adaptations are necessary to accommodate a larger body
size. HFD-BPA exposed males did not signiﬁcantly increase SV or CO
suggesting some impedance to LV function adaptation was  present.
The reduction in FS and increases in LVIDd and LVIDs as well as LV
volume in diastole in HFD-DES males versus CD-DES males suggests
reduced LV function and signiﬁcant LV dilation with DES exposure.
When CD and HFD females were compared, HFD-VEH females
were similar to their CD-VEH cohort suggesting that no additional
adaptations were necessary to adapt to the change in diet or body
size. HFD-BPA females had increased SV and increased PA VTI, but
were otherwise similar to their CD-BPA exposed cohort imply-
ing no large change in LV function. Similar to the males, HFD-DES
females had increased LV volume. Overall, cardiac function adap-
tations were more evident in DES-treated males and females than
in BPA-exposed mice.
3.5. Calcium homeostasis protein expression
To assess the remodeling accompanying chronic BPA exposure
and CD and HFD, we  isolated protein homogenates and measured
the expression levels of proteins involved in calcium homeosta-
sis, Fig. 3. Controlled calcium cycling is crucial to normal heart
function [1,22]. Calcium is released from the sarcoendoplasmic
reticulum (SER) to the cytosol for contraction and must be removed
from the cytosol, either back into the SER or to the extracellu-
lar space, for relaxation with each heart beat. Cardiac relaxation
is achieved by the activities of SERCA2a and the sodium-calcium
exchanger (NCX1) which transport calcium from the cytosol to the
SER or to the cell exterior, respectively [35]. SERCA2a activity is
reduced when it is bound by unphosphorylated phospholamban
(PLB). The ability to bind SERCA2a is lost, and thus SERCA2a activity
is increased, when PLB is phosphorylated on serine-16 (pS16-PLB).
Calsequestrin 2 (CASQ2) is a key calcium storage protein in the SER.
Additionally, NCX1, SERCA2a and CASQ2 expression is affected by
sex and sex hormones [23,34] as well as by BPA [4,62].
The expression pattern in CD-BPA and CD-DES males versus
CD-VEH mice, reduced SERCA2a coupled with no change in PLB
or pS16-PLB expression, predicts reduced SERCA2a activity. Simi-
larly within the HFD group, HFD-BPA males had reduced SERCA2a
expression with no change in PLB or pS16-PLB expression suggest-
ing the possibility for reduced SERCA2a activity. In females, the
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ncreased pS16-PLB with no change in PLB protein in CD-BPA and
D-DES versus CD-VEH females would be expected to increase
ERCA2a activity. Reductions in NCX1 expression suggests reduced
alcium efﬂux to the exterior in HFD-BPA and HFD-DES versus HFD-
EH females. Calcium storage capacity in CASQ2 is predicted to be
educed because of reduced CASQ2 protein in HFD-BPA and HFD-
ES females.
When expression in CD versus HFD mice was compared, HFD-
EH males showed reductions in SERCA2a and PLB compared with
D-VEH males. This pattern was replicated in CD-BPA versus HFD-
PA males suggesting no deﬁcit in remodeling with the HFD in
he BPA exposed males. However, CD-DES versus HFD-DES males
howed no expression changes suggesting an inability to remodel
ith HFD. In CD-VEH versus HFD-VEH females, only pS16-PLB was
ncreased in HFD-VEH females. HFD-BPA and HFD-DES females had
educed NCX1 and CASQ2, and increased pS16-PLB when compared
ith CD-BPA females. We  conclude that BPA and DES exposure
odiﬁed the expression of proteins involved in calcium handling
ith greater effects observed in females and on a HFD.
. Discussion
It is a paradox that whereas estrogen is generally beneﬁcial and
educes cardiovascular disease [34,57], increased exposure to the
strogenic endocrine disruptor BPA may  enhance cardiovascular
isease [29,36,37,55,56]. One major difference between estrogen
nd BPA exposures is that whereas women are exposed cyclically to
strogen, women and men  are exposed chronically to BPA leaching
rom food and beverage containers. Here, we measured the impact
f chronic oral exposure to BPA and gestational exposure to DES
n male and female mice in the context of a CD or HFD and found:
1) similar BW,  SBP and baseline ECG parameters in VEH, BPA and
ES mice fed the CD or HFD; (2) female-speciﬁc alterations in P-
ur and QRS after catecholamine challenge in BPA exposed mice;
3) induction of pericardial fat deposition in BPA- and DES-exposed
ice in absence of obesity; (4) female-speciﬁc development of car-
iac hypertrophy with BPA and DES; (5) reductions in LV systolic
unction in DES-, and not BPA-exposed mice; and (6) sex-speciﬁc
hanges in proteins important for calcium homeostasis. Our data
re signiﬁcant because they extend the results of acute exposure to
PA in ex vivo heart preparations to chronic exposure to BPA in mice.
hese data support the idea that other endocrine disrupting com-
ounds might inﬂuence rodent cardiac electrical conduction and
ardiac structure/function. Further, although there are multiple dif-
erences in cardiac physiology across species, these data strengthen
he idea that cardiac conduction and cardiac structure/function in
umans might be inﬂuenced by exposure to environmental chem-
cals, and that this exposure may  increase pathology.
The coordination of cardiac contraction is accomplished by the
ardiac conduction system. We  detected no change in surface ECG
arameters in either sex with chronic BPA or gestational DES expo-
ure in unstressed mice. It is possible that extended exposure to
PA may  be necessary to detect overt arrhythmia development
n the absence of challenge. We  found chronic exposure to BPA
ncreased the susceptibility to aberrant ECG conduction changes
ith catecholamine challenge only in females. These data extend
revious work which showed that the catecholamine response of
ardiomyocytes isolated from female rats acutely exposed to BPA
as greater than cardiomyocytes isolated from males [20,62]. Fur-
her, this increased susceptibility to BPA may  be most signiﬁcant
t times of sustained catecholamine release, such as during high
ntensity exercise or after an arrhythmia-promoting event such as a
yocardial infarction. Heart rate returned to baseline within 5 min
n all mice, indicating that catecholamine metabolism was  likely
naffected by treatment. Whereas BPA- and DES-exposed male and
emale mice increased pericardial fat, we found no change in ECGorts 2 (2015) 1310–1318
parameters at baseline in either sex or after catecholamine chal-
lenge in males. This suggests that increased pericardial fat per se
may  not induce arrhythmia.
Prolonged QRS intervals and dropped beats at high BPA concen-
trations were detected in ex vivo heart preparations isolated from
female rats using an optical mapping method to measure mem-
brane potential [46]. Although they did not explore the impact of
sex, these data support studies using isolated cardiac cells from
female and male animals which showed that acute BPA treatments
preferentially affected cardiac conduction in samples from female
hearts. We  extended these analyses to mice chronically exposed
to BPA in vivo and examined the impact of sex. We  found longer
QRS intervals when the heart rate was maximal in catecholamine-
stimulated BPA exposed females and no detectable impact in
similarly treated males. Besides the impact of BPA on the QRS
interval, we found a longer P-wave duration after catecholamine
injection. P-wave duration is recognized as a non-invasive marker
of atrial conduction and when it is prolonged has been associated
with an increase in atrial ﬁbrillation [45]. Together the data suggest
that acute and chronic exposure to BPA impairs cardiac conduc-
tion, may promote arrhythmia and that this is particularly evident
in exposed females.
BPA’s impact on cardiac conduction can be immediate as shown
by acute exposure and long term as shown in in vivo exposure
analyses. The potassium voltage-gated channel subfamily member
5 (KCN5) was  identiﬁed as a downregulated gene in microarray
analyses of fetal hearts exposed to BPA during gestation [12]. Inac-
tivating mutations in KCN5 in humans are associated with atrial
ﬁbrillation, and pharmacological inhibition of KCN5 led to atrial
ﬁbrillation on catecholamine challenge in mice [40]. Thus, BPA
exposure affected the expression of proteins important for con-
trol of cardiac conduction and that this impact begas in utero [6].
Besides inﬂuencing the expression of ion channel proteins, BPA
directly binds and inactivates cardiac ion channels. In vitro stud-
ies showed BPA binding and blocking the activity of the cardiac
sodium channel, hNAV1.5 [39] and the cardiac voltage-gated L-
type calcium channel [13]. Although, the physiological relevance of
BPA interactions with these ion channels remains unclear because
the concentrations of BPA necessary to inhibit channel activities
were several orders of magnitude greater than predicted serum
BPA concentrations, these data highlight that BPA exposure may
immediately increase the susceptibility to arrhythmia.
Our study shows no consequence to LV structure of chronic BPA
or gestation-only DES exposure in males fed the CD, but signiﬁ-
cant LV structural adaptation leading to concentric hypertrophy in
BPA- and DES-exposed females fed the CD. The protein base of a
diet as well as the presence of phytoestrogens in the diet can pro-
foundly inﬂuence cardiac outcomes in mice. In the current study,
LVM and RWT  were affected more in females than males when the
BPA-exposed mice were fed a CD which was casein-based. Previ-
ously, we  found LVM and RWT  were more affected in males than
females when the mice were exposed to similar, but not identi-
cal amounts of BPA, and fed a soy-based diet [43]. These differing
outcomes support other work which found that male mice fed soy-
based diets were particularly unable to adapt to stress whereas
male mice fed a casein-based diet were able to adapt [33,53]. In a
direct comparison, males with an inherited form of hypertrophic
cardiomyopathy developed dilation and heart failure when fed a
soy-based diet, yet had normal cardiac function when fed a casein-
based diet [53]. Together, these results show that sex, diet and
estrogenizing compounds interact and have a large impact on the
extent, and whether, cardiac pathology develops.The increase in LVM in BPA- and DES-exposed females with-
out an increase in SBP argues for a direct impact of BPA and DES to
increase LVM. Subcutaneous BPA injection of pregnant outbred MF-
1 mice induced a higher SBP in the adult male and female progeny
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9]. The different outcomes on SBP may  depend upon the mouse
train (inbred versus outbred), timing of exposure (chronic versus
estation-only) or dose (0.5 g/kg/day versus 100 g/kg/day) of
PA delivered. In our study, gestation-only treatment with DES
id not increase SBP in CD-DES mice. This argues that estrogenic
xposure during gestation may  not always lead to increased SBP.
e detected a small, non-hypertensive increase in SBP in HFD-
ES males. We  speculate that gestational estrogenic exposure of
ales may  increase the sensitivity to develop higher SBP when
nder a cardiometabolic stress, such as a HFD. Overall, chronic
PA-mediated cardiac structure changes showed a strong female-
reference.
Like the HFD-VEH males used in this study, HFD feeding to FVB
61] or C57bl/6 males [10] did not lead to demonstrable LV systolic
ysfunction or an increase in blood pressure. Similarly, we  did not
etect cardiac LV systolic dysfunction in CD-BPA or HFD-BPA male
r female mice. Preservation of normal cardiac structure/function
n the face of challenge is of paramount importance and is often
chieved by altered expression of calcium homeostasis proteins
35]. Expression of cardiac proteins, including those involved in cal-
ium homeostasis, differs in intact versus gonadectomized rodents
nd differs in male and female mice [15,23,34,52]. Previously, acute
PA exposure of ex vivo heart preparations sex-speciﬁcally altered
ERCA2a expression and activity, as wells as phosphorylation of the
ERCA2a inhibitor PLB [4,62]. Thus, proteins important for calcium
omeostasis are targets for estrogenic hormonal disruption. Our
ata extend these results; we found SERCA2a, NCX1 and CASQ2
xpression and PLB phosphorylation were signiﬁcantly and sex-
peciﬁcally altered in male and female mice chronically exposed to
PA. Further, we found that the combination of BPA and the HFD
ccentuated the changes in calcium homeostasis protein expres-
ion in females. Together, these results suggest that acute and
hronic exposure to BPA modify the expression and activity of
ardiac calcium handling proteins. Also, our data suggest that the
ormalization of LV function with chronic exposure to BPA required
ex-speciﬁc remodeling of calcium homeostasis proteins.
The ability of BPA to modulate the expression of these proteins
ay  have long term consequences and be downstream of the estro-
en receptor activation. Controlled expression of these proteins is
mportant because their expression is altered with cardiac physiol-
gy or pathologies, such as heart failure. In heart failure, SERCA2a
xpression is decreased and NCX1 is increased whereas CASQ2 is
enerally unaffected [7]. An inability to change SERCA2a, CASQ2
r phospholamban expression in single gene gene-modifed mice
as led to increased cardiac damage from various insults suggest-
ng that changes in their expression is a key feature for successful
ardiac remodeling when under stress [31,32,44,47]. These data
uggest that chronic BPA exposure may  reduce the capability to
ffect these changes and reduce the ability to cardiac remodel with
ormal stresses such as exercise or pathological stress such as with
atecholamine excess. Abnormalities in intracellular Ca2+ regula-
ion also profoundly disrupt the electrophysiological properties of
he heart. Mutations in CASQ2 as well as the ryanodine receptor
ead to an inability to modulate calcium into and out of the SER and
re associated with increased arrhythmogenesis [14,47]. It is likely
hat BPA exposure impacts expression of a number of cardiac pro-
eins. In other studies, outbred CD-1 mice sex-speciﬁc expression
f a multitude of cardiac mRNAs was found when the mice were
hronically exposed to a relatively high level of BPA [5]. Similar to
strogens, BPA activates nuclear and membrane estrogen recep-
ors [8,11]. Supporting a role for ER signaling as a mechanism for
PA effects in heart, ER blockade reduced BPA-mediated prolonged
rrhythmia events after ischemic/reperfusion in acutely exposed ex
ivo female hearts [58,63]. Further, no spontaneous after contrac-
ions were detected in ER-deﬁcient hearts [62]. Together these
ata show that acute and chronic BPA exposure induces cardiac
[
[orts 2 (2015) 1310–1318 1317
conduction and expression changes, suggest that these changes are
likely downstream of ER signaling.
5. Conclusions
Epidemiology studies have correlated increased BPA exposure
with increased obesity. Obesity increases the risk for cardiac hyper-
trophy development and arrhythmia promotion. Our results show
that chronic exposure to BPA from mid-gestation to euthanasia
at 4 months of age did not substantially increase body weight,
cardiac hypertrophy or induce overt arrhythmia in lean or obese
male mice. In contrast, BPA’s impact was most evident in exposed
females versus similar exposed males and was manifest as sex-
speciﬁc changes in the expression of calcium homeostasis proteins
and in an enhanced response to catecholamine stimulation in sur-
face ECG analysis. These data suggest that chronic BPA exposure
alters cardiac contraction and relaxation and alters coordination of
this contraction by the cardiac conduction system. The enhanced
responses in exposed female mice supports the idea that BPA-
mediated activation of estrogen receptors is part of the mechanism
for its adverse impact in heart and suggests the possibility that
women experiencing a cardiac crisis may  be particularly sensitive
to BPA’s adverse effects.
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